EZH2 and neoplasm: However, most patients with FL have at least 2 mutations in chromatin-modifying proteins that can serve to prevent B cells from exiting the germinal center, making it easier for the EZH2 protein to maintain transcriptional repression unchecked, and, in such cases, the tumor can be susceptible to EZH2 repression [4, 7–10].